Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
about
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimuriumCell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging.Is DNA methylation the new guardian of the genome?Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chEvaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella.Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation.Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
P2860
Q33829258-5D92FB31-EA2A-4A01-95F1-EC4093382500Q33914020-5D797854-0548-440A-A297-C439C8976C13Q38742078-9C3DC699-C346-4380-92CC-E97B494E726EQ39233074-D5AB3F7B-CC5F-46D1-ACF0-145CA6FD6EEEQ46005533-3790694D-950A-4B51-B003-F0310B4AAD1CQ46198099-172062CE-06C1-4CE5-8663-C2E4DFC62B95Q48156221-A84269CF-1E05-4651-AD6F-8A837905AC9CQ48572985-1C46E99D-E192-4874-9066-F34D190D1A78Q50317370-6DCFCD6D-30FB-4692-BF20-5DCE8F77A968Q50333648-FC58478F-1B6A-4522-BC60-F4C1F9E2B738Q52603159-03F599EF-1839-40FF-93DE-11C7BE4C3BC8Q53688087-F7303CD0-2AD3-4802-A642-361DFCE9A879Q55076815-17F9A472-DDDB-4B36-A8E8-A3D4028CDE9A
P2860
Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@en
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@nl
type
label
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@en
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@nl
prefLabel
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@en
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@nl
P2093
P2860
P1433
P1476
Tumor-specific cell-cycle deco ...... s visualized by FUCCI imaging.
@en
P2093
Kiyoto Takehara
Michael Bouvet
Qinghong Han
Robert M Hoffman
Shukuan Li
Shuya Yano
Toshiyoshi Fujiwara
Yuying Tan
P2860
P304
P356
10.1080/15384101.2016.1181240
P577
2016-05-06T00:00:00Z